DGI:Endokarditis/Quellen: Difference between revisions

From Infektiopedia
imported>Bestem
imported>Fuhrmanns
No edit summary
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
==Quellen==
<span style="font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;
mso-fareast-font-family:Calibri;mso-ansi-language:EN-US"><span style="mso-list:Ignore">1. <span style="font:7.0pt &quot;Times New Roman&quot;">      </span></span></span><span style="font-size:8.0pt;mso-bidi-font-size:
11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-ansi-language:EN-US">healthcare professionals from the American Heart Association; Circulation (2015); 132(15):1435</span>


<span style="font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;
1. AATS Surgical Treatment of Infective Endocarditis Consensus Guidelines Writing Committee Chairs, Pettersson GB, Coselli JS, et al. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive summary. J Thorac Cardiovasc Surg. 2017;153(6):1241-1258.e29. doi:10.1016/j.jtcvs.2016.09.093
mso-fareast-font-family:Calibri;mso-ansi-language:EN-US"><span style="mso-list:Ignore">2. <span style="font:7.0pt &quot;Times New Roman&quot;">      </span></span></span><span style="font-size:8.0pt;mso-bidi-font-size:
11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-ansi-language:EN-US">2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC); European Heart Journal (2015); 36(44):3075-3128</span>


<span style="font-size:8.0pt;mso-bidi-font-size:11.0pt;
2. Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882-893. doi:10.1016/S0140-6736(15)00067-7
font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-font-family:Calibri;mso-ansi-language:
EN-US"><span style="mso-list:Ignore">3. <span style="font:7.0pt &quot;Times New Roman&quot;">      </span></span></span><span style="font-size:8.0pt;mso-bidi-font-size:
11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-ansi-language:EN-US">The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive Summary; The Journal of Thoracic and Cardiovascular Surgery (2017); 153(6):1241</span>


<span style="font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;
3. Duval X, Delahaye F, Alla F, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012;59(22):1968-1976. doi:10.1016/j.jacc.2012.02.029
mso-fareast-font-family:Calibri;mso-ansi-language:EN-US"><span style="mso-list:Ignore">4. <span style="font:7.0pt &quot;Times New Roman&quot;">      </span></span></span><span style="font-size:8.0pt;mso-bidi-font-size:
11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-ansi-language:EN-US">2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.Heart Rhythm. 2017 Dec;14(12):e503-e551</span>


<span style="mso-list:Ignore">5. <span style="font:7.0pt &quot;Times New Roman&quot;">      </span></span><span style="font-size:8.0pt;mso-bidi-font-size:
4. Duval X, Le Moing V, Tubiana S, et al. Impact of Systematic Whole-body 18F-Fluorodeoxyglucose PET/CT on the Management of Patients Suspected of Infective Endocarditis: The Prospective Multicenter TEPvENDO Study. Clin Infect Dis. 2021;73(3):393-403. doi:10.1093/cid/ciaa666
11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-ansi-language:EN-US">Focaccia Siciliano R, Azevedo Randi B, Menosi Gualandro D et al: Early-onset prosthetic valve endocarditis definition revisited: Prospective study and literature review. Int J Inf Dis 2018, 67: 3-6.</span>


<span style="mso-list:Ignore">6. <span style="font:7.0pt &quot;Times New Roman&quot;">      </span></span><span style="color: #222222">POET - partial oral treatment of left-sided infectious endocarditis; Ivesen K et al. </span>N Engl J Med. 28. August 2018. <nowiki>https://doi.org/10.1056/NEJMoa1808312</nowiki>
5. Fusco FM, Pisapia R, Nardiello S, Cicala SD, Gaeta GB, Brancaccio G. Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005–2015 systematic review. BMC Infectious Diseases. 2019;19(1):653. doi:10.1186/s12879-019-4285-8
 
6. Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14(12):e503-e551. doi:10.1016/j.hrthm.2017.09.001
 
7. Selton-Suty C, Célard M, Le Moing V, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54(9):1230-1239. doi:10.1093/cid/cis199
 
8. Siciliano RF, Randi BA, Gualandro DM, et al. Early-onset prosthetic valve endocarditis definition revisited: Prospective study and literature review. Int J Infect Dis. 2018;67:3-6. doi:10.1016/j.ijid.2017.09.004
 
9. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association - PubMed. Accessed March 15, 2022. <nowiki>https://pubmed.ncbi.nlm.nih.gov/26373316/</nowiki>
 
10. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis | NEJM. Accessed March 15, 2022. <nowiki>https://www.nejm.org/doi/10.1056/NEJMoa1808312</nowiki>
<br />
<br />

Latest revision as of 20:12, 17 March 2022

1. AATS Surgical Treatment of Infective Endocarditis Consensus Guidelines Writing Committee Chairs, Pettersson GB, Coselli JS, et al. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive summary. J Thorac Cardiovasc Surg. 2017;153(6):1241-1258.e29. doi:10.1016/j.jtcvs.2016.09.093

2. Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882-893. doi:10.1016/S0140-6736(15)00067-7

3. Duval X, Delahaye F, Alla F, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012;59(22):1968-1976. doi:10.1016/j.jacc.2012.02.029

4. Duval X, Le Moing V, Tubiana S, et al. Impact of Systematic Whole-body 18F-Fluorodeoxyglucose PET/CT on the Management of Patients Suspected of Infective Endocarditis: The Prospective Multicenter TEPvENDO Study. Clin Infect Dis. 2021;73(3):393-403. doi:10.1093/cid/ciaa666

5. Fusco FM, Pisapia R, Nardiello S, Cicala SD, Gaeta GB, Brancaccio G. Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005–2015 systematic review. BMC Infectious Diseases. 2019;19(1):653. doi:10.1186/s12879-019-4285-8

6. Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14(12):e503-e551. doi:10.1016/j.hrthm.2017.09.001

7. Selton-Suty C, Célard M, Le Moing V, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54(9):1230-1239. doi:10.1093/cid/cis199

8. Siciliano RF, Randi BA, Gualandro DM, et al. Early-onset prosthetic valve endocarditis definition revisited: Prospective study and literature review. Int J Infect Dis. 2018;67:3-6. doi:10.1016/j.ijid.2017.09.004

9. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association - PubMed. Accessed March 15, 2022. https://pubmed.ncbi.nlm.nih.gov/26373316/

10. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis | NEJM. Accessed March 15, 2022. https://www.nejm.org/doi/10.1056/NEJMoa1808312